Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Pieris Pharmaceuticals, Inc.. (8/10/16). "Press Release: Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Second Quarter Ended June 30, 2016". Boston, MA.

Organisations Organisation Pieris Pharmaceuticals Inc. (Nasdaq: PIRS)
  Group Pieris (Group)
  Organisation 2 BVF Partners L.P. (Biotechnology Venture Fund)
Products Product PRS-080 (Anticalin hepcidin antagonist)
  Product 2 PRS-060/AZD1402 (anti-IL4Ra Anticalin, Pieris/AstraZeneca)
Persons Person Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP)
  Person 2 Deptula-Hicks, Darlene (Pieris 201509–201702 CFO before consultant to Pieris RESIGNED 2/17)
     


   
Record changed: 2021-06-10

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Pieris (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px




» top